Estrogen carcinogenesis in breast cancer

JD Yager, NE Davidson - New England Journal of Medicine, 2006 - Mass Medical Soc
Estrogen Carcinogenesis in Breast Cancer | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

[HTML][HTML] Sex, gender, and sex hormones in pulmonary hypertension and right ventricular failure

J Hester, C Ventetuolo, T Lahm - Comprehensive Physiology, 2019 - ncbi.nlm.nih.gov
Pulmonary hypertension (PH) encompasses a syndrome of diseases that are characterized
by elevated pulmonary artery pressure and pulmonary vascular remodeling and that …

Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells

Y Chen, E McMillan-Ward, J Kong, SJ Israels… - Cell Death & …, 2008 - nature.com
Autophagy is a self-digestion process that degrades intracellular structures in response to
stresses leading to cell survival. When autophagy is prolonged, this could lead to cell death …

2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF

NJ Mabjeesh, D Escuin, TM LaVallee, VS Pribluda… - Cancer cell, 2003 - cell.com
Inhibition of angiogenesis is an important new modality for cancer treatment. 2-
methoxyestradiol (2ME2) is a novel antitumor and antiangiogenic agent, currently in clinical …

HIF-1 as a target for drug development

A Giaccia, BG Siim, RS Johnson - Nature reviews Drug discovery, 2003 - nature.com
Sensing and responding to fluxes in oxygen tension is perhaps the single most important
variable in physiology, and animal tissues have developed a number of essential …

Steroid sulfatase: molecular biology, regulation, and inhibition

MJ Reed, A Purohit, LWL Woo, SP Newman… - Endocrine …, 2005 - academic.oup.com
Steroid sulfatase (STS) is responsible for the hydrolysis of aryl and alkyl steroid sulfates and
therefore has a pivotal role in regulating the formation of biologically active steroids. The …

Endogenous inhibitors of angiogenesis

P Nyberg, L Xie, R Kalluri - Cancer research, 2005 - AACR
Angiogenesis, the formation of new blood vessels, is required for many pathologic
processes, including invasive tumor growth as well as physiologic organ/tissue …

Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy

KE Arnst, S Banerjee, H Chen, S Deng… - Medicinal research …, 2019 - Wiley Online Library
Microtubule (MT)‐targeting agents are highly successful drugs as chemotherapeutic agents,
and this is attributed to their ability to target MT dynamics and interfere with critical cellular …

Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents

Y Zhou, EO Hileman, W Plunkett… - Blood, The Journal …, 2003 - ashpublications.org
Methoxyestradiol (2-ME), a new anticancer agent currently in clinical trials, has been
demonstrated to inhibit superoxide dismutase (SOD) and to induce apoptosis in leukemia …

2‐Methoxyestradiol, a promising anticancer agent

NJ Lakhani, MA Sarkar, J Venitz… - … : The Journal of Human …, 2003 - Wiley Online Library
Estrogens occurring naturally in the body are metabolized to catecholestrogens (2‐and 4‐
hydroxyestradiol) by the cytochrome P450 enzymes. 2‐Hydroxy catecholestrogens are …